Wang Huan, Liang Jixiang, Zhang Gen, He Dongsheng, Du Baoluo, Ren Zhipeng, Dai Ziqiang, Lee Hsin, Li Dianyuan
Department of Cardiovascular Surgery, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, 215008 Suzhou, Jiangsu, China.
The State Key Laboratory for Manufacturing Systems Engineering, Xi'an Jiaotong University, 710000 Xi'an, Shaanxi, China.
Rev Cardiovasc Med. 2024 Mar 11;25(3):101. doi: 10.31083/j.rcm2503101. eCollection 2024 Mar.
Multimodal imaging plays a crucial role in evaluating suspected cardiac tumours. In recent years, three-dimensional (3D) printing technology has continued to advance such that image-based 3D-printed models have been incorporated into the auxiliary diagnosis and treatment of cardiac tumour diseases. The purpose of this review is to analyze the existing literature on the application of 3D printing in cardiac tumour surgery to examine the current status of the application of this technology.
By searching PubMed, Cochrane, Scopus and Google Scholar, as well as other resource databases, a completed review of the available literature was performed. Effect sizes from published studies were investigated, and results are presented concerning the use of 3D surgical planning in the management of cardiac tumours.
According to the reviewed literature, our study comes to the point that 3D printing is a valuable technique for planning surgery for cardiac tumours. As shown in the review report, Mucinous and sarcomatous tumours are the most commonly used tumours for 3D printing, magnetic resonance imaging (MRI) and computed tomography (CT) are the most commonly used technologies for preparing 3D printing models, the main printing technology is stereolithography, and the most used 3D modeling software is Mimics. The printing time and cost required for 3D printing are affected by factors such as the size of the type, complexity, the printed material and the 3D printing technology used. The reported research shows that 3D printing can understand the anatomy of complex tumour cases, virtual surgical simulation, as well as facilitate doctor-patient communication and clinical teaching.
These results show that the development of 3D printing technology has brought more accurate and safe perioperative treatment options for patients with cardiac tumours. Therefore, 3D printing technology is expected to become a routine clinical diagnosis and treatment tool for cardiac tumours.
多模态成像在评估疑似心脏肿瘤方面发挥着关键作用。近年来，三维（3D）打印技术不断发展，基于图像的3D打印模型已被应用于心脏肿瘤疾病的辅助诊断和治疗。本综述的目的是分析现有关于3D打印在心脏肿瘤手术中应用的文献，以研究该技术的应用现状。
通过检索PubMed、Cochrane、Scopus和谷歌学术以及其他资源数据库，对现有文献进行了全面综述。调查了已发表研究的效应大小，并给出了关于3D手术规划在心脏肿瘤管理中的应用结果。
根据综述文献，我们的研究得出结论，3D打印是一种用于心脏肿瘤手术规划的有价值技术。如综述报告所示，黏液性和肉瘤性肿瘤是3D打印最常用的肿瘤类型，磁共振成像（MRI）和计算机断层扫描（CT）是制备3D打印模型最常用的技术，主要打印技术是立体光刻，最常用的3D建模软件是Mimics。3D打印所需的打印时间和成本受模型类型大小、复杂性、打印材料以及所使用的3D打印技术等因素影响。报告的研究表明，3D打印能够了解复杂肿瘤病例的解剖结构、进行虚拟手术模拟，还能促进医患沟通和临床教学。
这些结果表明，3D打印技术的发展为心脏肿瘤患者带来了更准确、安全的围手术期治疗选择。因此，3D打印技术有望成为心脏肿瘤常规的临床诊断和治疗工具。
